Stay updated on BOS-580 in NASH Obese Subjects Clinical Trial
Sign up to get notified when there's something new on the BOS-580 in NASH Obese Subjects Clinical Trial page.

Latest updates to the BOS-580 in NASH Obese Subjects Clinical Trial page
- Check6 days agoChange DetectedRemoved coverage of MedlinePlus Genetics topics on Non-alcoholic fatty liver disease; no new topics were added.SummaryDifference0.3%
- Check13 days agoChange Detected- Added a government-operating-status notice and links; - Added a new MedlinePlus Genetics topic on Non-alcoholic fatty liver disease; - Updated revision from v3.1.0 to v3.2.0.SummaryDifference3%
- Check20 days agoChange DetectedUpdated to Revision: v3.1.0 with several drug-safety topics removed (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and a new version tag added; signifies a scope/priorities shift toward the new release.SummaryDifference0.4%
- Check27 days agoChange DetectedSignificant additions include a new update window and a collaborator (GSK Research and Development Limited), plus a more recent date stamp (2025-09) and an estimated last update notice; deletions remove the older MedlinePlus Genetics topic on non-alcoholic fatty liver disease and earlier last update postings. Overall, the page appears to be refreshed with newer metadata and collaboration details, with some older topic references removed.SummaryDifference1%
- Check35 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the old revision label was removed. The 'Back to Top' element was also removed, which is a minor UI change.SummaryDifference0.2%
- Check42 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
Stay in the know with updates to BOS-580 in NASH Obese Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BOS-580 in NASH Obese Subjects Clinical Trial page.